New pharmacological and technological management strategies in heart failure

References

• YancyCWJessupMBozkurtB2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20136216e147e23923747642
   PubMed Web of Science ®Google Scholar
• Writing GroupMMozaffarianDBenjaminEJAmerican Heart Association Statistics Committee; Stroke Statistics SubcommitteeHeart disease and stroke statistics-2016 update: a report from the American Heart AssociationCirculation20161334e38e36026673558
   PubMed Web of Science ®Google Scholar
• BuiALHorwichTBFonarowGCEpidemiology and risk profile of heart failureNat Rev Cardiol201181304121060326
   PubMed Web of Science ®Google Scholar
• HallMJDeFrancesCJWilliamsSNGolosinskiyASchwartzmanANational hospital discharge survey: 2007 summaryNat Health Stat Report20102912024
   Google Scholar
• Anne StaylorRNMSHeart failure therapy: past, present, and future2002 Available from: http://www.medscape.org/viewarticle/433746Accessed November 1, 2016
   Google Scholar
• RogerVLWestonSARedfieldMMTrends in heart failure incidence and survival in a community-based populationJAMA2004292334435015265849
   PubMed Web of Science ®Google Scholar
• HeidenreichPAAlbertNMAllenLAForecasting the impact of heart failure in the United States: a policy statement from the American Heart AssociationCirc Heart Fail20136360661923616602
   PubMed Web of Science ®Google Scholar
• CohnJNArchibaldDGZiescheSEffect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative StudyN Engl J Med198631424154715523520315
   PubMed Web of Science ®Google Scholar
• FonarowGCYancyCWHernandezAFPetersonEDSpertusJAHeidenreichPAPotential impact of optimal implementation of evidence-based heart failure therapies on mortalityAm Heart J2011161610241030.e102321641346
   PubMed Web of Science ®Google Scholar
• VerbruggeFHTangWHMullensWRenin-angiotensin-aldosterone system activation during decongestion in acute heart failure: friend or foe?JACC Heart Fail20153210811125543974
   PubMed Web of Science ®Google Scholar
• JhundPSMcMurrayJJThe neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartanHeart2016102171342134727207980
   PubMed Web of Science ®Google Scholar
• MentzRJStevensSRDeVoreADDecongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failureJACC Heart Fail2015329710725543972
   PubMed Web of Science ®Google Scholar
• VardenyOMillerRSolomonSDCombined neprilysin and renin-angiotensin system inhibition for the treatment of heart failureJACC Heart Fail20142666367025306450
   PubMed Web of Science ®Google Scholar
• Bayes-GenisANeprilysin in heart failure: from oblivion to center stageJACC Heart Fail20153863764026251091
   PubMed Web of Science ®Google Scholar
• PackerMCaliffRMKonstamMAComparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)Circulation2002106892092612186794
   PubMed Web of Science ®Google Scholar
• RuilopeLMDukatABohmMLacourciereYGongJLefkowitzMPBlood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator studyLancet201037597221255126620236700
   PubMed Web of Science ®Google Scholar
• SolomonSDZileMPieskeBThe angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trialLancet201238098511387139522932717
   PubMed Web of Science ®Google Scholar
• McMurrayJJPackerMDesaiASPARADIGM-HF Investigators and CommitteesAngiotensin-neprilysin inhibition versus enalapril in heart failureN Engl J Med201437111993100425176015
   PubMed Web of Science ®Google Scholar
• DesaiASIntensive management to reduce hospitalizations in patients with heart failureCirculation2016133171704170727143153
   PubMed Web of Science ®Google Scholar
• DesaiASMcMurrayJJPackerMEffect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patientsEur Heart J201536301990199726022006
   PubMed Web of Science ®Google Scholar
• YancyCWJessupMBozkurtB2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of AmericaCirculation201613413e282e29327208050
   PubMed Web of Science ®Google Scholar
• GillmanMWKannelWBBelangerAD’AgostinoRBInfluence of heart rate on mortality among persons with hypertension: the Framing-ham StudyAm Heart J19931254114811548465742
   PubMed Web of Science ®Google Scholar
• FoxKFordIStegPGTenderaMRobertsonMFerrariRBeautiful investigatorsHeart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trialLancet2008372964181782118757091
   PubMed Web of Science ®Google Scholar
• PocockSJWangDPfefferMAPredictors of mortality and morbidity in patients with chronic heart failureEur Heart J2006271657516219658
   PubMed Web of Science ®Google Scholar
• Perret-GuillaumeCJolyLBenetosAHeart rate as a risk factor for cardiovascular diseaseProg Cardiovasc Dis200952161019615487
   PubMed Web of Science ®Google Scholar
• DiFrancescoDFunny channels in the control of cardiac rhythm and mode of action of selective blockersPharmacol Res200653539940616638640
   PubMed Web of Science ®Google Scholar
• DiFrancescoDBorerJSThe funny current: cellular basis for the control of heart rateDrugs200767Suppl 2152417999560
   PubMed Web of Science ®Google Scholar
• SwedbergKKomajdaMBohmMIvabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyLancet2010376974487588520801500
   PubMed Web of Science ®Google Scholar
• BarkerWHMulloolyJPGetchellWChanging incidence and survival for heart failure in a well-defined older population, 1970–1974 and 1990–1994Circulation2006113679980516461823
   PubMed Web of Science ®Google Scholar
• BradleyEHCurryLHorwitzLIHospital strategies associated with 30-day readmission rates for patients with heart failureCirc Cardiovasc Qual Outcomes20136444445023861483
   PubMed Web of Science ®Google Scholar
• LogeartDThabutGJourdainPPredischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failureJ Am Coll Cardiol200443463564114975475
   PubMed Web of Science ®Google Scholar
• LalaADSVaderJZakeriRRavichandranAAbouEzzadineOKhazaniePMcNultySThe tides of congestion during and after hospitalization for acute decompensated heart failureJ Cardiac Fail2013198S81
   Web of Science ®Google Scholar
• GrafftCAMcDonaldFSRuudKLLiesingerJTJohnsonMGNaessensJMEffect of hospital follow-up appointment on clinical event outcomes and mortalityArch Intern Med20101701195596020548008
   PubMedGoogle Scholar
• LowrieRMairFSGreenlawNHeart Failure Optimal Outcomes from Pharmacy Study (HOOPS) InvestigatorsPharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunctionEur Heart J201233331432422083873
   PubMed Web of Science ®Google Scholar
• ChaudhrySIMatteraJACurtisJPTelemonitoring in patients with heart failureN Engl J Med2010363242301230921080835
   PubMed Web of Science ®Google Scholar
• KoehlerFWinklerSSchieberMTelemedical Interventional Monitoring in Heart Failure InvestigatorsImpact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure studyCirculation2011123171873188021444883
   PubMed Web of Science ®Google Scholar
• OngMKRomanoPSEdgingtonSEffectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the better effectiveness after transition – heart failure (BEAT-HF) randomized clinical trialJAMA Intern Med2016176331031826857383
   PubMed Web of Science ®Google Scholar
• AdamsonPBPathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devicesCurr Heart Fail Rep20096428729219948098
   PubMedGoogle Scholar
• AdamsonPBAbrahamWTAaronMCHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring systemJ Card Fail201117131021187258
   PubMed Web of Science ®Google Scholar
• AbrahamWTAdamsonPBBourgeRCCHAMPION Trial Study GroupWireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trialLancet2011377976665866621315441
   PubMed Web of Science ®Google Scholar
• AbrahamWTStevensonLWBourgeRCLindenfeldJABaumanJGAdamsonPBCHAMPION Trial Study GroupSustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trialLancet20163871001745346126560249
   PubMed Web of Science ®Google Scholar
• ManciniDColomboPCLeft ventricular assist devices: a rapidly evolving alternative to transplantJ Am Coll Cardiol201565232542255526065994
   PubMed Web of Science ®Google Scholar
• MillerLWPaganiFDRussellSDHeartMate II Clinical InvestigatorsUse of a continuous-flow device in patients awaiting heart transplantationN Engl J Med2007357988589617761592
   PubMed Web of Science ®Google Scholar
• SlaughterMSRogersJGMilanoCAHeartMate II InvestigatorsAdvanced heart failure treated with continuous-flow left ventricular assist deviceN Engl J Med2009361232241225119920051
   PubMed Web of Science ®Google Scholar
• AaronsonKDSlaughterMSMillerLWHeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial InvestigatorsUse of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantationCirculation2012125253191320022619284
   PubMed Web of Science ®Google Scholar
• StewartGCGivertzMMMechanical circulatory support for advanced heart failure: patients and technology in evolutionCirculation2012125101304131522412091
   PubMed Web of Science ®Google Scholar
• MoazamiNFukamachiKKobayashiMAxial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practiceJ Heart Lung Transplant201332111123260699
   PubMed Web of Science ®Google Scholar
• LaroseJATamezDAshenugaMReyesCDesign concepts and principle of operation of the HeartWare ventricular assist systemASAIO J201056428528920559135
   PubMed Web of Science ®Google Scholar
• McIlvennanCKMagidKHAmbardekarAVThompsonJSMatlockDDAllenLAClinical outcomes after continuous-flow left ventricular assist device: a systematic reviewCirc Heart Fail2014761003101325294625
   PubMed Web of Science ®Google Scholar
• HeatleyGSoodPGoldsteinDClinical trial design and rationale of the multicenter study of MagLev technology in patients undergoing mechanical circulatory support therapy with heartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocolJ Heart Lung Transplant201635452853627044532
   PubMed Web of Science ®Google Scholar
• SchmittoJDHankeJSRojasSVAvsarMHaverichAFirst implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III)J Heart Lung Transplant201534685886025920932
   PubMed Web of Science ®Google Scholar
• NetukaISoodPPyaYFully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter studyJ Am Coll Cardiol201566232579258926670056
   PubMed Web of Science ®Google Scholar
• ZimpferDNetukaISchmittoJDMulticentre clinical trial experience with the HeartMate 3 left ventricular assist device: 30-day outcomesEur J Cardiothorac Surg201650354855427436871
   PubMed Web of Science ®Google Scholar
• SlaughterMSPaganiFDMcGeeECHeartWare Bridge to Transplant ADVANCE Trial InvestigatorsHeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trialJ Heart Lung Transplant201332767568323796152
   PubMed Web of Science ®Google Scholar
• MehraMRNakaYUrielNMOMENTUM 3 InvestigatorsA fully magnetically levitated circulatory pump for advanced heart failureN Engl J Med Epub20161126
   PubMed Web of Science ®Google Scholar
• MetraMTachycardia after a heart failure hospitalization: another piece of the puzzle?JACC Heart Fail20131649749924622001
   PubMed Web of Science ®Google Scholar
• CrozierISmithWModern device technologiesHeart Lung Circulation2012216–7320327
   PubMed Web of Science ®Google Scholar
• ShavelleDJermynRThe CardioMEMS heart failure sensor: a procedural guide for implanting physiciansJ Invasive Cardiol201628727327927342204
   PubMed Web of Science ®Google Scholar